Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel alpha-ketoamide inhibitor with activity against main protease of SARS-CoV-2

April 7, 2020

IRF-1 as a novel therapeutic target in CKD

April 7, 2020

Mesoblast's IND for remestemcel-L in COVID-19-related ARDS receives clearance

April 7, 2020

AXS-07 achieves both coprimary endpoints in INTERCEPT phase III study

April 7, 2020

European Commission approves Nilemdo and Nustendi

April 7, 2020

Millendo Therapeutics discontinues development of livoletide for PWS

April 7, 2020

Opaganib approved for compassionate use in patients with COVID-19 in Italy

April 7, 2020

First patient dosed in phase I study of COM-902 in advanced malignancies

April 7, 2020

Glycoprotein negatively regulates adult neurogenesis

April 7, 2020

Ennaid begins development of ENU-200 for COVID-19 infection

April 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Circulating sncRNA transcriptome in diabetic kidney disease and SGLT2 inhibitor treatment
BioWorld Science
Small noncoding RNAs (sncRNAs), including miRNAs, piRNAs and snoRNAs, can provide further biological insights into the mechanisms of chronic kidney disease (CKD)...